nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—Upset stomach—Disulfiram—alcohol dependence	0.0246	0.0546	CcSEcCtD
Plerixafor—CXCR4—Peptide GPCRs—OPRK1—alcohol dependence	0.0236	0.0669	CbGpPWpGaD
Plerixafor—CXCR4—forebrain—alcohol dependence	0.0212	0.108	CbGeAlD
Plerixafor—CXCR4—adrenal cortex—alcohol dependence	0.0197	0.0999	CbGeAlD
Plerixafor—CXCR4—cardiovascular system—alcohol dependence	0.018	0.0912	CbGeAlD
Plerixafor—CXCR4—pancreas—alcohol dependence	0.0175	0.0886	CbGeAlD
Plerixafor—Induration—Naltrexone—alcohol dependence	0.0168	0.0373	CcSEcCtD
Plerixafor—CXCR4—Peptide GPCRs—OPRD1—alcohol dependence	0.0159	0.045	CbGpPWpGaD
Plerixafor—CXCR4—digestive system—alcohol dependence	0.0149	0.0757	CbGeAlD
Plerixafor—Eye swelling—Citalopram—alcohol dependence	0.0146	0.0324	CcSEcCtD
Plerixafor—CXCR4—blood—alcohol dependence	0.0142	0.0721	CbGeAlD
Plerixafor—CXCR4—midbrain—alcohol dependence	0.014	0.0712	CbGeAlD
Plerixafor—Platelet count decreased—Naltrexone—alcohol dependence	0.0126	0.028	CcSEcCtD
Plerixafor—CXCR4—endocrine gland—alcohol dependence	0.0123	0.0626	CbGeAlD
Plerixafor—CXCR4—Peptide GPCRs—OPRM1—alcohol dependence	0.0122	0.0346	CbGpPWpGaD
Plerixafor—CXCR4—testis—alcohol dependence	0.0117	0.0597	CbGeAlD
Plerixafor—CXCR4—nervous system—alcohol dependence	0.0115	0.0585	CbGeAlD
Plerixafor—Upset stomach—Naltrexone—alcohol dependence	0.0115	0.0255	CcSEcCtD
Plerixafor—CXCR4—Peptide ligand-binding receptors—OPRK1—alcohol dependence	0.0111	0.0315	CbGpPWpGaD
Plerixafor—CXCR4—liver—alcohol dependence	0.0111	0.0564	CbGeAlD
Plerixafor—CXCR4—central nervous system—alcohol dependence	0.0111	0.0564	CbGeAlD
Plerixafor—CXCR4—cerebellum—alcohol dependence	0.0108	0.0551	CbGeAlD
Plerixafor—Abdominal discomfort—Disulfiram—alcohol dependence	0.00969	0.0215	CcSEcCtD
Plerixafor—CXCR4—G alpha (i) signalling events—OPRK1—alcohol dependence	0.00937	0.0265	CbGpPWpGaD
Plerixafor—CXCR4—brain—alcohol dependence	0.00881	0.0448	CbGeAlD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—OPRK1—alcohol dependence	0.00869	0.0246	CbGpPWpGaD
Plerixafor—Platelet count decreased—Citalopram—alcohol dependence	0.008	0.0178	CcSEcCtD
Plerixafor—Haematoma—Citalopram—alcohol dependence	0.00757	0.0168	CcSEcCtD
Plerixafor—Injection site reaction—Naltrexone—alcohol dependence	0.00747	0.0166	CcSEcCtD
Plerixafor—CXCR4—Peptide ligand-binding receptors—OPRD1—alcohol dependence	0.00746	0.0211	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—OPRK1—alcohol dependence	0.00745	0.0211	CbGpPWpGaD
Plerixafor—Upset stomach—Citalopram—alcohol dependence	0.00726	0.0161	CcSEcCtD
Plerixafor—CXCR4—Peptide ligand-binding receptors—PDYN—alcohol dependence	0.00716	0.0203	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—OPRD1—alcohol dependence	0.0063	0.0178	CbGpPWpGaD
Plerixafor—Swelling—Naltrexone—alcohol dependence	0.00618	0.0137	CcSEcCtD
Plerixafor—CXCR4—G alpha (i) signalling events—PDYN—alcohol dependence	0.00604	0.0171	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—OPRD1—alcohol dependence	0.00584	0.0166	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—OPRM1—alcohol dependence	0.00574	0.0163	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—OPRK1—alcohol dependence	0.00567	0.0161	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—NPY—alcohol dependence	0.00529	0.015	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CHRM2—alcohol dependence	0.00528	0.015	CbGpPWpGaD
Plerixafor—Orthostatic hypotension—Acamprosate—alcohol dependence	0.00526	0.0117	CcSEcCtD
Plerixafor—Paraesthesia—Disulfiram—alcohol dependence	0.00516	0.0115	CcSEcCtD
Plerixafor—Abdominal distension—Acamprosate—alcohol dependence	0.00501	0.0111	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	0.00501	0.0142	CbGpPWpGaD
Plerixafor—Fatigue—Disulfiram—alcohol dependence	0.00496	0.011	CcSEcCtD
Plerixafor—Pain—Disulfiram—alcohol dependence	0.00492	0.0109	CcSEcCtD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—CHRM2—alcohol dependence	0.0049	0.0139	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—OPRM1—alcohol dependence	0.00484	0.0137	CbGpPWpGaD
Plerixafor—Musculoskeletal pain—Citalopram—alcohol dependence	0.00482	0.0107	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.0048	0.0136	CbGpPWpGaD
Plerixafor—Abdominal discomfort—Naltrexone—alcohol dependence	0.00452	0.01	CcSEcCtD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—OPRM1—alcohol dependence	0.0045	0.0127	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—NPY—alcohol dependence	0.00446	0.0126	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—HTR1B—alcohol dependence	0.0043	0.0122	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	0.0042	0.0119	CbGpPWpGaD
Plerixafor—Asthenia—Disulfiram—alcohol dependence	0.00412	0.00916	CcSEcCtD
Plerixafor—Haemoglobin—Acamprosate—alcohol dependence	0.00401	0.0089	CcSEcCtD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	0.00399	0.0113	CbGpPWpGaD
Plerixafor—Haemorrhage—Acamprosate—alcohol dependence	0.00399	0.00886	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.00385	0.0109	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—OPRD1—alcohol dependence	0.00381	0.0108	CbGpPWpGaD
Plerixafor—Dizziness—Disulfiram—alcohol dependence	0.0038	0.00845	CcSEcCtD
Plerixafor—CXCR4—G alpha (i) signalling events—DRD4—alcohol dependence	0.00376	0.0107	CbGpPWpGaD
Plerixafor—Connective tissue disorder—Naltrexone—alcohol dependence	0.00371	0.00823	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—PDYN—alcohol dependence	0.00366	0.0104	CbGpPWpGaD
Plerixafor—Rash—Disulfiram—alcohol dependence	0.00362	0.00805	CcSEcCtD
Plerixafor—Headache—Disulfiram—alcohol dependence	0.0036	0.008	CcSEcCtD
Plerixafor—Immune system disorder—Acamprosate—alcohol dependence	0.0036	0.008	CcSEcCtD
Plerixafor—CXCR4—G alpha (i) signalling events—CNR1—alcohol dependence	0.00359	0.0102	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—EP300—alcohol dependence	0.00359	0.0102	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.00355	0.01	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—DRD2—alcohol dependence	0.0035	0.00992	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—AVP—alcohol dependence	0.00349	0.0099	CbGpPWpGaD
Plerixafor—Mental disorder—Acamprosate—alcohol dependence	0.00349	0.00776	CcSEcCtD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	0.00349	0.00989	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.00342	0.00969	CbGpPWpGaD
Plerixafor—Flatulence—Acamprosate—alcohol dependence	0.00342	0.0076	CcSEcCtD
Plerixafor—Immune system disorder—Naltrexone—alcohol dependence	0.00341	0.00757	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—CRHR1—alcohol dependence	0.0034	0.00963	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	0.00333	0.00944	CbGpPWpGaD
Plerixafor—Mental disorder—Naltrexone—alcohol dependence	0.0033	0.00734	CcSEcCtD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	0.00325	0.00921	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	0.00325	0.00921	CbGpPWpGaD
Plerixafor—Flatulence—Naltrexone—alcohol dependence	0.00324	0.00719	CcSEcCtD
Plerixafor—Ill-defined disorder—Acamprosate—alcohol dependence	0.00322	0.00715	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—OPRK1—alcohol dependence	0.00321	0.00908	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CHRM2—alcohol dependence	0.0032	0.00905	CbGpPWpGaD
Plerixafor—Orthostatic hypotension—Citalopram—alcohol dependence	0.00315	0.00701	CcSEcCtD
Plerixafor—Malaise—Acamprosate—alcohol dependence	0.00313	0.00695	CcSEcCtD
Plerixafor—Syncope—Acamprosate—alcohol dependence	0.00311	0.00691	CcSEcCtD
Plerixafor—Loss of consciousness—Acamprosate—alcohol dependence	0.00305	0.00678	CcSEcCtD
Plerixafor—Ill-defined disorder—Naltrexone—alcohol dependence	0.00305	0.00677	CcSEcCtD
Plerixafor—Abdominal distension—Citalopram—alcohol dependence	0.00301	0.00668	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.00299	0.00847	CbGpPWpGaD
Plerixafor—Malaise—Naltrexone—alcohol dependence	0.00296	0.00658	CcSEcCtD
Plerixafor—Arthralgia—Acamprosate—alcohol dependence	0.00295	0.00656	CcSEcCtD
Plerixafor—Syncope—Naltrexone—alcohol dependence	0.00294	0.00654	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00293	0.00652	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—OPRM1—alcohol dependence	0.00293	0.00831	CbGpPWpGaD
Plerixafor—Discomfort—Acamprosate—alcohol dependence	0.00292	0.00648	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—OPRK1—alcohol dependence	0.00291	0.00825	CbGpPWpGaD
Plerixafor—Dry mouth—Acamprosate—alcohol dependence	0.00289	0.00642	CcSEcCtD
Plerixafor—Loss of consciousness—Naltrexone—alcohol dependence	0.00289	0.00641	CcSEcCtD
Plerixafor—Abdominal discomfort—Citalopram—alcohol dependence	0.00286	0.00636	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.00285	0.00809	CbGpPWpGaD
Plerixafor—Anaphylactic shock—Acamprosate—alcohol dependence	0.00283	0.00629	CcSEcCtD
Plerixafor—Arthralgia—Naltrexone—alcohol dependence	0.0028	0.00621	CcSEcCtD
Plerixafor—Shock—Acamprosate—alcohol dependence	0.00279	0.00619	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.00279	0.00789	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.00279	0.00789	CbGpPWpGaD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00278	0.00617	CcSEcCtD
Plerixafor—Discomfort—Naltrexone—alcohol dependence	0.00276	0.00613	CcSEcCtD
Plerixafor—Skin disorder—Acamprosate—alcohol dependence	0.00275	0.00611	CcSEcCtD
Plerixafor—Hyperhidrosis—Acamprosate—alcohol dependence	0.00274	0.00608	CcSEcCtD
Plerixafor—Dry mouth—Naltrexone—alcohol dependence	0.00273	0.00607	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—NPY—alcohol dependence	0.0027	0.00765	CbGpPWpGaD
Plerixafor—Anaphylactic shock—Naltrexone—alcohol dependence	0.00268	0.00595	CcSEcCtD
Plerixafor—Shock—Naltrexone—alcohol dependence	0.00264	0.00586	CcSEcCtD
Plerixafor—Nervous system disorder—Naltrexone—alcohol dependence	0.00263	0.00584	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—CRH—alcohol dependence	0.0026	0.00738	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—HTR1B—alcohol dependence	0.0026	0.00738	CbGpPWpGaD
Plerixafor—Skin disorder—Naltrexone—alcohol dependence	0.0026	0.00578	CcSEcCtD
Plerixafor—Hyperhidrosis—Naltrexone—alcohol dependence	0.00259	0.00575	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00258	0.00573	CcSEcCtD
Plerixafor—Insomnia—Acamprosate—alcohol dependence	0.00256	0.00569	CcSEcCtD
Plerixafor—Paraesthesia—Acamprosate—alcohol dependence	0.00254	0.00565	CcSEcCtD
Plerixafor—Dyspnoea—Acamprosate—alcohol dependence	0.00252	0.00561	CcSEcCtD
Plerixafor—Dyspepsia—Acamprosate—alcohol dependence	0.00249	0.00554	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00244	0.00543	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00244	0.00542	CcSEcCtD
Plerixafor—Insomnia—Naltrexone—alcohol dependence	0.00242	0.00538	CcSEcCtD
Plerixafor—Constipation—Acamprosate—alcohol dependence	0.00242	0.00538	CcSEcCtD
Plerixafor—Pain—Acamprosate—alcohol dependence	0.00242	0.00538	CcSEcCtD
Plerixafor—Paraesthesia—Naltrexone—alcohol dependence	0.00241	0.00534	CcSEcCtD
Plerixafor—Haemoglobin—Citalopram—alcohol dependence	0.0024	0.00534	CcSEcCtD
Plerixafor—Haemorrhage—Citalopram—alcohol dependence	0.00239	0.00531	CcSEcCtD
Plerixafor—Dyspnoea—Naltrexone—alcohol dependence	0.00239	0.00531	CcSEcCtD
Plerixafor—Connective tissue disorder—Citalopram—alcohol dependence	0.00235	0.00522	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.00234	0.00664	CbGpPWpGaD
Plerixafor—Feeling abnormal—Acamprosate—alcohol dependence	0.00233	0.00518	CcSEcCtD
Plerixafor—CXCR4—Peptide ligand-binding receptors—POMC—alcohol dependence	0.00232	0.00658	CbGpPWpGaD
Plerixafor—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00232	0.00514	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00231	0.00514	CcSEcCtD
Plerixafor—Fatigue—Naltrexone—alcohol dependence	0.00231	0.00513	CcSEcCtD
Plerixafor—Pain—Naltrexone—alcohol dependence	0.00229	0.00509	CcSEcCtD
Plerixafor—Constipation—Naltrexone—alcohol dependence	0.00229	0.00509	CcSEcCtD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.00228	0.00645	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—DRD4—alcohol dependence	0.00228	0.00645	CbGpPWpGaD
Plerixafor—Urticaria—Acamprosate—alcohol dependence	0.00225	0.005	CcSEcCtD
Plerixafor—Abdominal pain—Acamprosate—alcohol dependence	0.00224	0.00497	CcSEcCtD
Plerixafor—Feeling abnormal—Naltrexone—alcohol dependence	0.00221	0.0049	CcSEcCtD
Plerixafor—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00219	0.00487	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—CNR1—alcohol dependence	0.00217	0.00616	CbGpPWpGaD
Plerixafor—Immune system disorder—Citalopram—alcohol dependence	0.00216	0.00479	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—OPRD1—alcohol dependence	0.00215	0.0061	CbGpPWpGaD
Plerixafor—Urticaria—Naltrexone—alcohol dependence	0.00213	0.00473	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—DRD2—alcohol dependence	0.00212	0.00601	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—HTR7—alcohol dependence	0.00212	0.00601	CbGpPWpGaD
Plerixafor—Abdominal pain—Naltrexone—alcohol dependence	0.00212	0.00471	CcSEcCtD
Plerixafor—Mental disorder—Citalopram—alcohol dependence	0.00209	0.00465	CcSEcCtD
Plerixafor—Hypersensitivity—Acamprosate—alcohol dependence	0.00209	0.00464	CcSEcCtD
Plerixafor—Erythema—Citalopram—alcohol dependence	0.00208	0.00462	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—PDYN—alcohol dependence	0.00207	0.00585	CbGpPWpGaD
Plerixafor—Flatulence—Citalopram—alcohol dependence	0.00205	0.00455	CcSEcCtD
Plerixafor—Asthenia—Acamprosate—alcohol dependence	0.00203	0.00451	CcSEcCtD
Plerixafor—Pruritus—Acamprosate—alcohol dependence	0.002	0.00445	CcSEcCtD
Plerixafor—Hypersensitivity—Naltrexone—alcohol dependence	0.00197	0.00439	CcSEcCtD
Plerixafor—CXCR4—G alpha (i) signalling events—POMC—alcohol dependence	0.00196	0.00555	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—OPRD1—alcohol dependence	0.00196	0.00554	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.00195	0.00553	CbGpPWpGaD
Plerixafor—Diarrhoea—Acamprosate—alcohol dependence	0.00194	0.0043	CcSEcCtD
Plerixafor—Ill-defined disorder—Citalopram—alcohol dependence	0.00193	0.00429	CcSEcCtD
Plerixafor—Asthenia—Naltrexone—alcohol dependence	0.00192	0.00427	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CRHR1—alcohol dependence	0.00192	0.00544	CbGpPWpGaD
Plerixafor—Pruritus—Naltrexone—alcohol dependence	0.0019	0.00421	CcSEcCtD
Plerixafor—Malaise—Citalopram—alcohol dependence	0.00188	0.00417	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—PDYN—alcohol dependence	0.00188	0.00531	CbGpPWpGaD
Plerixafor—Dizziness—Acamprosate—alcohol dependence	0.00187	0.00416	CcSEcCtD
Plerixafor—Syncope—Citalopram—alcohol dependence	0.00187	0.00414	CcSEcCtD
Plerixafor—Diarrhoea—Naltrexone—alcohol dependence	0.00183	0.00407	CcSEcCtD
Plerixafor—Loss of consciousness—Citalopram—alcohol dependence	0.00183	0.00406	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CHRM2—alcohol dependence	0.00181	0.00512	CbGpPWpGaD
Plerixafor—Vomiting—Acamprosate—alcohol dependence	0.0018	0.004	CcSEcCtD
Plerixafor—Rash—Acamprosate—alcohol dependence	0.00179	0.00397	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—AVP—alcohol dependence	0.00179	0.00506	CbGpPWpGaD
Plerixafor—Dermatitis—Acamprosate—alcohol dependence	0.00178	0.00396	CcSEcCtD
Plerixafor—Headache—Acamprosate—alcohol dependence	0.00177	0.00394	CcSEcCtD
Plerixafor—Dizziness—Naltrexone—alcohol dependence	0.00177	0.00394	CcSEcCtD
Plerixafor—Arthralgia—Citalopram—alcohol dependence	0.00177	0.00393	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.00176	0.00391	CcSEcCtD
Plerixafor—Discomfort—Citalopram—alcohol dependence	0.00175	0.00389	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CRHR1—alcohol dependence	0.00174	0.00494	CbGpPWpGaD
Plerixafor—Dry mouth—Citalopram—alcohol dependence	0.00173	0.00385	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—OPRK1—alcohol dependence	0.00172	0.00487	CbGpPWpGaD
Plerixafor—Vomiting—Naltrexone—alcohol dependence	0.0017	0.00378	CcSEcCtD
Plerixafor—Anaphylactic shock—Citalopram—alcohol dependence	0.0017	0.00377	CcSEcCtD
Plerixafor—Rash—Naltrexone—alcohol dependence	0.00169	0.00375	CcSEcCtD
Plerixafor—Dermatitis—Naltrexone—alcohol dependence	0.00169	0.00375	CcSEcCtD
Plerixafor—Nausea—Acamprosate—alcohol dependence	0.00168	0.00374	CcSEcCtD
Plerixafor—Headache—Naltrexone—alcohol dependence	0.00168	0.00373	CcSEcCtD
Plerixafor—Shock—Citalopram—alcohol dependence	0.00167	0.00371	CcSEcCtD
Plerixafor—Nervous system disorder—Citalopram—alcohol dependence	0.00166	0.0037	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—OPRM1—alcohol dependence	0.00166	0.0047	CbGpPWpGaD
Plerixafor—Skin disorder—Citalopram—alcohol dependence	0.00165	0.00366	CcSEcCtD
Plerixafor—Hyperhidrosis—Citalopram—alcohol dependence	0.00164	0.00365	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CHRM2—alcohol dependence	0.00164	0.00465	CbGpPWpGaD
Plerixafor—Nausea—Naltrexone—alcohol dependence	0.00159	0.00354	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.00156	0.00441	CbGpPWpGaD
Plerixafor—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.00155	0.00344	CcSEcCtD
Plerixafor—Insomnia—Citalopram—alcohol dependence	0.00154	0.00341	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—NPY—alcohol dependence	0.00153	0.00432	CbGpPWpGaD
Plerixafor—Paraesthesia—Citalopram—alcohol dependence	0.00152	0.00339	CcSEcCtD
Plerixafor—Dyspnoea—Citalopram—alcohol dependence	0.00151	0.00336	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—OPRM1—alcohol dependence	0.00151	0.00427	CbGpPWpGaD
Plerixafor—Dyspepsia—Citalopram—alcohol dependence	0.00149	0.00332	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—HTR2A—alcohol dependence	0.00149	0.00421	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—HTR1B—alcohol dependence	0.00147	0.00417	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CRH—alcohol dependence	0.00147	0.00417	CbGpPWpGaD
Plerixafor—Gastrointestinal disorder—Citalopram—alcohol dependence	0.00147	0.00326	CcSEcCtD
Plerixafor—Fatigue—Citalopram—alcohol dependence	0.00146	0.00325	CcSEcCtD
Plerixafor—Constipation—Citalopram—alcohol dependence	0.00145	0.00323	CcSEcCtD
Plerixafor—Pain—Citalopram—alcohol dependence	0.00145	0.00323	CcSEcCtD
Plerixafor—Feeling abnormal—Citalopram—alcohol dependence	0.0014	0.00311	CcSEcCtD
Plerixafor—Gastrointestinal pain—Citalopram—alcohol dependence	0.00139	0.00308	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—NPY—alcohol dependence	0.00139	0.00393	CbGpPWpGaD
Plerixafor—Urticaria—Citalopram—alcohol dependence	0.00135	0.003	CcSEcCtD
Plerixafor—Abdominal pain—Citalopram—alcohol dependence	0.00134	0.00298	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—HTR1B—alcohol dependence	0.00134	0.00379	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CRH—alcohol dependence	0.00134	0.00379	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—DRD4—alcohol dependence	0.00129	0.00365	CbGpPWpGaD
Plerixafor—Hypersensitivity—Citalopram—alcohol dependence	0.00125	0.00278	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CNR1—alcohol dependence	0.00123	0.00348	CbGpPWpGaD
Plerixafor—Asthenia—Citalopram—alcohol dependence	0.00122	0.00271	CcSEcCtD
Plerixafor—Pruritus—Citalopram—alcohol dependence	0.0012	0.00267	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—DRD2—alcohol dependence	0.0012	0.0034	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—HTR7—alcohol dependence	0.0012	0.0034	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—POMC—alcohol dependence	0.00119	0.00336	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—DRD4—alcohol dependence	0.00117	0.00331	CbGpPWpGaD
Plerixafor—Diarrhoea—Citalopram—alcohol dependence	0.00116	0.00258	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—OPRD1—alcohol dependence	0.00116	0.00327	CbGpPWpGaD
Plerixafor—Dizziness—Citalopram—alcohol dependence	0.00112	0.00249	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CNR1—alcohol dependence	0.00112	0.00316	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PDYN—alcohol dependence	0.00111	0.00314	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—DRD2—alcohol dependence	0.00109	0.00308	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—HTR7—alcohol dependence	0.00109	0.00308	CbGpPWpGaD
Plerixafor—Vomiting—Citalopram—alcohol dependence	0.00108	0.0024	CcSEcCtD
Plerixafor—Rash—Citalopram—alcohol dependence	0.00107	0.00238	CcSEcCtD
Plerixafor—Dermatitis—Citalopram—alcohol dependence	0.00107	0.00238	CcSEcCtD
Plerixafor—Headache—Citalopram—alcohol dependence	0.00106	0.00236	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—WASF2—alcohol dependence	0.00103	0.00292	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CRHR1—alcohol dependence	0.00103	0.00292	CbGpPWpGaD
Plerixafor—CXCR4—Disease—GOT2—alcohol dependence	0.00102	0.00289	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—AVP—alcohol dependence	0.00101	0.00286	CbGpPWpGaD
Plerixafor—Nausea—Citalopram—alcohol dependence	0.00101	0.00224	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—WASF1—alcohol dependence	0.000988	0.0028	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CHRM2—alcohol dependence	0.000969	0.00274	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—AVP—alcohol dependence	0.000916	0.0026	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—OPRM1—alcohol dependence	0.000889	0.00252	CbGpPWpGaD
Plerixafor—CXCR4—Disease—GOT1—alcohol dependence	0.00088	0.00249	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—HTR2A—alcohol dependence	0.000839	0.00238	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NPY—alcohol dependence	0.000818	0.00232	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HTR1B—alcohol dependence	0.00079	0.00224	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CRH—alcohol dependence	0.00079	0.00224	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—HTR2A—alcohol dependence	0.000762	0.00216	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—DRD4—alcohol dependence	0.00069	0.00196	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—POMC—alcohol dependence	0.00067	0.0019	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CNR1—alcohol dependence	0.000659	0.00187	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HTR7—alcohol dependence	0.000643	0.00182	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—DRD2—alcohol dependence	0.000643	0.00182	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—POMC—alcohol dependence	0.000609	0.00172	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AVP—alcohol dependence	0.000541	0.00153	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HTR2A—alcohol dependence	0.00045	0.00128	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—POMC—alcohol dependence	0.00036	0.00102	CbGpPWpGaD
Plerixafor—CXCR4—Disease—EP300—alcohol dependence	0.000341	0.000965	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—EP300—alcohol dependence	0.000239	0.000676	CbGpPWpGaD
